Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Illumina Inc (ILMN)

Illumina Inc (ILMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Illumina Inc 5200 ILLUMINA WAY SAN DIEGO CA 92122 USA

www.illumina.com Employees: 9,300 P: 858-202-4500 F: 858-202-4545

Description:

Illumina Inc. is a life sciences company, which provides tools and integrated systems for analysis of genetic variation and function. Using its proprietary technologies, the company provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, and gene expression profiling of DNA and RNA. Its customers include leading genomic research centers, academic institutions, government laboratories, hospitals and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic and consumer genomics companies. Illumina generates revenue from two segments - Product and Service. Product are primarily attributed to the partnerships and collaborations to develop distributable clinical in-vitro diagnostics for Illumina sequencers. Service include genotyping and sequencing services as well as instrument maintenance contracts.

Key Statistics

Overview:

Market Capitalization, $K 23,184,522
Enterprise Value, $K 23,625,522
Shares Outstanding, K 159,300
Annual Sales, $ 4,504 M
Annual Net Income, $ -1,161 M
Last Quarter Sales, $ 1,112 M
Last Quarter Net Income, $ -1,988 M
EBIT, $ 48,000 K
EBITDA, $ 480,000 K
60-Month Beta 1.15
% of Insider Shareholders 0.17%
% of Institutional Shareholders 89.42%
Float, K 159,029
% Float 99.83%
Short Volume Ratio 0.58

Growth:

1-Year Return 5.52%
3-Year Return -64.50%
5-Year Return -52.97%
5-Year Revenue Growth 35.13%
5-Year Earnings Growth -84.97%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.36 on 08/06/24
Next Earnings Date 11/04/24
Earnings Per Share ttm 0.92
EPS Growth vs. Prev Qtr 300.00%
EPS Growth vs. Prev Year 12.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 341.12%
Most Recent Split 2-1 on 09/23/08

ILMN Ratios

Ratio
Price/Earnings ttm 158.20
Price/Earnings forward 40.15
Price/Earnings to Growth N/A
Return-on-Equity % 3.08%
Return-on-Assets % 1.60%
Profit Margin % -25.78%
Debt/Equity 1.04
Price/Sales 5.15
Price/Cash Flow 40.62
Price/Book 16.15
Book Value/Share 9.01
Interest Coverage -13.51
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar